PT Soho Global Health Tbk (ISX:SOHO) Beneish M-Score: -2.81 (As of Sep. 06, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ISX:SOHO PT Soho Global Health Tbk ISX:SOHO
87 GF Score
Price Rp1,205.00
GF Value Rp805.04
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is PT Soho Global Health Tbk Beneish M-Score?

PT Soho Global Health Tbk ISX:SOHO +0.42% 87 Beneish M-Score is -2.81 as of Sep. 06, 2026. GuruFocus rates ISX:SOHO with a GF Score™ of 87/100 and a GF Value™ of Rp805.04 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 118 Medical Distribution companies, PT Soho Global Health Tbk ranks better than 83.9% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.81 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for PT Soho Global Health Tbk's Beneish M-Score or its related term are showing as below:

ISX:SOHO' s Beneish M-Score Range Over the Past 10 Years
Min: -2.84   Med: -2.26   Max: -1.75
Current: -2.81

During the past 7 years, the highest Beneish M-Score of PT Soho Global Health Tbk was -1.75. The lowest was -2.84. And the median was -2.26.


PT Soho Global Health Tbk Beneish M-Score Historical Data

* Premium members only.

The historical data trend for PT Soho Global Health Tbk's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Soho Global Health Tbk Beneish M-Score Chart

PT Soho Global Health Tbk Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beneish M-Score
Get a 7-Day Free Trial -2.72 -2.27 -2.10 -1.75 -2.84

PT Soho Global Health Tbk Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.34 -2.71 -2.84 -2.73 -2.81

ISX:SOHO vs MCK, COR, CAH: Beneish M-Score Comparison

For the Medical Distribution subindustry, PT Soho Global Health Tbk's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PT Soho Global Health Tbk Beneish M-Score vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, PT Soho Global Health Tbk's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where PT Soho Global Health Tbk's Beneish M-Score falls into.


ISX:SOHO
87GF Score
PT Soho Global Health Tbk ISX:SOHO
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PT Soho Global Health Tbk Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of PT Soho Global Health Tbk for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.0083+0.528 * 0.8608+0.404 * 0.9343+0.892 * 1.0606+0.115 * 0.94
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.1996+4.679 * -0.045899-0.327 * 1.1087
=-2.81

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Jun26) TTM:Last Year (Jun25) TTM:
Total Receivables was Rp2,528,954 Mil.
Revenue was 2726781 + 2635637 + 2854681 + 2755513 = Rp10,972,612 Mil.
Gross Profit was 539327 + 532294 + 495354 + 448110 = Rp2,015,085 Mil.
Total Current Assets was Rp4,966,088 Mil.
Total Assets was Rp5,594,308 Mil.
Property, Plant and Equipment(Net PPE) was Rp484,363 Mil.
Depreciation, Depletion and Amortization(DDA) was Rp49,537 Mil.
Selling, General, & Admin. Expense(SGA) was Rp578,867 Mil.
Total Current Liabilities was Rp2,936,269 Mil.
Long-Term Debt & Capital Lease Obligation was Rp2,631 Mil.
Net Income was 183064 + 189858 + 160228 + 149733 = Rp682,883 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = Rp0 Mil.
Cash Flow from Operations was 324210 + 143763 + 194337 + 277346 = Rp939,656 Mil.
Total Receivables was Rp2,364,944 Mil.
Revenue was 2498075 + 2670918 + 2587244 + 2589575 = Rp10,345,812 Mil.
Gross Profit was 411045 + 449927 + 386536 + 388010 = Rp1,635,518 Mil.
Total Current Assets was Rp4,815,847 Mil.
Total Assets was Rp5,477,568 Mil.
Property, Plant and Equipment(Net PPE) was Rp510,970 Mil.
Depreciation, Depletion and Amortization(DDA) was Rp48,821 Mil.
Selling, General, & Admin. Expense(SGA) was Rp454,999 Mil.
Total Current Liabilities was Rp2,591,223 Mil.
Long-Term Debt & Capital Lease Obligation was Rp4,179 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(2528954 / 10972612) / (2364944 / 10345812)
=0.230479 / 0.22859
=1.0083

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(1635518 / 10345812) / (2015085 / 10972612)
=0.158085 / 0.183647
=0.8608

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (4966088 + 484363) / 5594308) / (1 - (4815847 + 510970) / 5477568)
=0.025715 / 0.027522
=0.9343

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=10972612 / 10345812
=1.0606

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(48821 / (48821 + 510970)) / (49537 / (49537 + 484363))
=0.087213 / 0.092783
=0.94

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(578867 / 10972612) / (454999 / 10345812)
=0.052756 / 0.043979
=1.1996

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((2631 + 2936269) / 5594308) / ((4179 + 2591223) / 5477568)
=0.525338 / 0.473824
=1.1087

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(682883 - 0 - 939656) / 5594308
=-0.045899

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

PT Soho Global Health Tbk has a M-score of -2.81 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -2.81 mean?
PT Soho Global Health Tbk (ISX:SOHO) has a Beneish M-Score of -2.81 as of Sep. 06, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on PT Soho Global Health Tbk and its competitors. According to the industry distribution chart, PT Soho Global Health Tbk ranks #19 out of 118 companies in the Medical Distribution industry, placing it in the top 16.1%.
Is PT Soho Global Health Tbk's Beneish M-Score too high?
PT Soho Global Health Tbk's current Beneish M-Score is -2.81. Based on the distribution chart, PT Soho Global Health Tbk ranks #19 out of 118 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, PT Soho Global Health Tbk has a GF Score™ of 87/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does PT Soho Global Health Tbk's Beneish M-Score compare to MCK and COR?
According to the Medical Distribution industry distribution chart, PT Soho Global Health Tbk ranks #19 out of 118 companies for Beneish M-Score. This places PT Soho Global Health Tbk in the top 16% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Medical Distribution company?
A good Beneish M-Score depends on the Medical Distribution industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on PT Soho Global Health Tbk and its competitors. PT Soho Global Health Tbk's current Beneish M-Score is -2.81. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Soho Global Health Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Soho Global Health Tbk (ISX:SOHO) is currently considered Significantly Overvalued. The stock's GF Value™ is Rp805.04, compared to a current price of Rp1,205.00 — trading 49.7% above its estimated fair value. The current Beneish M-Score is -2.81. PT Soho Global Health Tbk's overall GF Score™ is 87/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For PT Soho Global Health Tbk (ISX:SOHO), the current Beneish M-Score is -2.81 as of Sep. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PT Soho Global Health Tbk (ISX:SOHO) Overvalued in 2026?

Based on GuruFocus' analysis, PT Soho Global Health Tbk stock appears to be overvalued. The current stock price of Rp1,205.00 is trading 49.7% above its estimated GF Value™ of Rp805.04. GuruFocus considers PT Soho Global Health Tbk to be Significantly Overvalued.

Key valuation signals for ISX:SOHO:

  • Beneish M-Score: -2.81
  • GF Value™: Rp805.04 vs. price of Rp1,205.00 (49.7% above fair value)
  • GF Score™: 87/100 with 3 warning signs

No single metric tells the full story. See the ISX:SOHO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


PT Soho Global Health Tbk Business Description

Address Jalan Rawa Sumur II Kav BB No. 3, Kawasan Industri Pulogadung, Kel., Jatinegara, Kec. Cakung, Jakarta Timur, Jakarta, IDN, 13930
PT Soho Global Health Tbk is a healthcare company operating in the areas of natural/herbal health care products and services. The company manufactures and distributes pharmaceutical products, including herbal cures, proprietary medicines, and health foods, under various brand names such as Curcuma Plus, Curcuma Plus Milk; Imboost; Fitkom; Diapet; Laxing; Lelap; Asthma Soho, and Sohobion. Its segment includes Distribution, Consumer health, Alliance, and others. The company generates maximum revenue from the Distribution segment.
87GF Score

Get the complete analysis for ISX:SOHO

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp1,205.00
Price
Rp805.04
GF Value